CHMP5 and COVID-19: While numerous vaccines have been deployed to prevent SARS-CoV-2 infection, and several immunological therapies have been authorized for treating COVID-19 patients, we are in a race against time to keep pace with the emergence of antigenically distinct SARS-CoV-2 variants that carry critical mutations in the spike protein.